Skip to main content
. 2020 Jul 7;59(21):2757–2761. doi: 10.2169/internalmedicine.5077-20

Table 1.

Patient’s Laboratory Data on Admission.

<Complete Blood Count> <Coagulation>
WBC 10,360 /μL PT 10.3 s BUN 10.1 mg/dL
RBC 425 ×104/μL APTT 28.9 s Cre 0.72 mg/dL
Hb 13.3 g/dL Fib 386 mg/dL UA 4.3 mg/dL
Het 40.2 % FDP <2.5 μg/mL Na 141 mmol/L
MCV 94.4 fL D-dimer <0.5 μg/mL Cl 109 mmol/L
MCH 31.3 pg <Biochemistry> K 3.9 mmol/L
MCHC 33.1 g/dL TP 6.8 g/dL Ca 8.7 mg/dL
PLT 286 ×103/μL Alb 4.0 g/dL IP 3.7 mg/dL
Seg 64.0 % T-Bil 0.38 mg/dL CRP 0.04 mg/dL
St 0.5 % AST 14 IU/L IgG 1,081.2 ng/mL
Ly 19.5 % ALT 14 IU/L IgA 156.4 ng/mL
Mon 6.5 % ALP 195 IU/L IgM 85.2 pg/mL
Eos 2.5 % γ-GTP 17 IU/L sIL-2R 3,228 U/mL
Bas 0 % ChE 291 IU/L
Abnormal-Ly 7.0 % LDH 267 IU/L

WBC: white blood cells, RBC: red blood cells, Hb: hemoglobin, Het: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, PLT: platelets, Seg: segmented cell, St: stab cell, Ly: lymphocyte, Mon: monocyte, Eos: eosinophils, Bas: basophils, Abnormal-Ly: abnormal lymphocytes, PT: prothrombin time, APTT: activated partial thromboplastin time, Fib: fibrinogen, FDP: fibrin/fibrinogen degradation products, TP: total protein, Alb: albumin, T-Bil: total bilirubin, AST: aspartate aminotransaminase, ALT: alanine aminotransaminase, ALP: alkaline phosphatase, γ-GTP: gamma glutamyltranspeptidase, ChE: cholinesterase, LDH: lactate dehydrogenase, BUN: blood urea nitrogen, Cre: creatinine, UA: uric acid, Na: natrium, Cl: chloride, K: potassium, Ca: calcium, IP: inorganic phosphorus, CRP: C-reactive protein, IgG: immunoglobulin G, IgA: immunoglobulin A, IgM: immunoglobulin M, sIL-2R: soluble interleukin-2 receptor